CARINA interim analysis: A non-interventional study of real-world treatment sequencing and outcomes in patients with advanced renal cell carcinoma initiated on first-line checkpoint inhibitor-based combination therapy.

Authors

null

Paul D. Nathan

Mount Vernon Cancer Center, Northwood, United Kingdom

Paul D. Nathan , Jennifer Allison , Natalie Charnley , Agnieszka Michael , Kathryn Moore , Anand Sharma , Bhupinder Klair , Valérie Perrot , James Larkin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Clinical Trial Registration Number

NCT04957160

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 626)

DOI

10.1200/JCO.2023.41.6_suppl.626

Abstract #

626

Poster Bd #

E16

Abstract Disclosures

Similar Posters

First Author: Pratik Rane

First Author: Daniel M. Geynisman

First Author: Kevin Yan